Forbes December 30, 2025
After raising $293 million in the IPO, Insilico Medicine aims to become “a massive source of innovative drugs for pharma companies,” says founder Alex...
Forbes December 30, 2025
After raising $293 million in the IPO, Insilico Medicine aims to become “a massive source of innovative drugs for pharma companies,” says founder Alex...